ArticleEvolution, medicine, and public health2026
The evaluation of facial features as markers of cardiometabolic health in women of post-reproductive age.
Article in Evolution, medicine, and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The early-life environment has a significant influence on health in later life, including the risk of cardiometabolic diseases (CMDs). Several biomarkers have been proposed as putative indicators of early-life environmental quality, including facial fluctuating asymmetry (FA) and facial averageness (AVE). This study aimed to explore the association between facial FA and AVE with CMDs risk factors in women of post-reproductive age. Methods: The participants were 248 post-reproductive women (M = 61.6, SD = 10.70) from the Mogielica Human Ecology Study Site in Poland. Standardized facial photographs were taken, and FA and AVE were calculated using geometric morphometrics. Fasting blood samples were collected, and blood pressure was measured directly. Body composition was assessed via bioelectrical impedance analysis. CMDs risk factors included blood pressure, total cholesterol, high-density and low-density lipoproteins, triglycerides, and glucose levels. Additionally, the risk of metabolic syndrome was determined for each participant. Cardiovascular disease risk was also evaluated using the Systematic Coronary Risk Estimation scale (SCORE). FA and AVE were modelled separately against each CMDs risk factor using hierarchical linear and logistic models. Results: No statistically significant associations were found between either FA or AVE and individual CMDs risk factors. Similarly, no relationships were observed between facial measurements and either SCORE or metabolic syndrome risk. Follow-up Bayesian analyses provided evidence that FA and AVE did not predict CMDs risk factors. Conclusions and implications: While facial asymmetry and averageness may influence perceptions of health, they are unlikely to serve as biomarkers of CMDs risk in older women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.